Electrophoresis Market Size, Share & Trends Analysis Report By Product (Electrophoresis Reagents, Systems), By Application, By End-use (Academic and Research Institutes), By Region, And Segment Forecasts, 2024 - 2030

Electrophoresis Market Size & Trends

The global electrophoresis market size was estimated at USD 3,176.46 million in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2030. This growth is attributed to the increasing prevalence of chronic diseases such as CVD and cancer, increasing industry academia collaborations coupled with the rising need for personalized medicines and technological advancements are major factors driving the market. Furthermore, increasing funding for genomics and proteomics research and rising number of clinical laboratories are likely to drive the market over the forecast period.

The rising prevalence of cancer and infectious diseases is driving the need for early diagnosis. In February 2024, WHO estimated the global cancer burden to reach an estimated number of 35 million new cases by 2050, a 77 % rise to that of 20 million in 2022. This increasing prevalence is driving demand for advanced diagnostic and treatment technologies, including electrophoresis reagents and systems. Electrophoresis is a crucial technique used in cancer research, diagnosis, and monitoring, enabling the separation and analysis of proteins, nucleic acids, and other biomolecules. Lung cancer is the leading cause of cancer death worldwide, accounting for 1.8 million deaths 18.7% of total cancer deaths in 2022.

Collaborations between academic institutions and industry players are fostering innovation in electrophoretic techniques, particularly in the fields of genomics, proteomics, and personalized medicine. These partnerships are leveraging advanced electrophoresis technologies to identify biomarkers, study disease mechanisms at a molecular level, and develop targeted therapies tailored to individual genetic profiles. Moreover, the increasing integration of high-throughput electrophoresis systems in clinical diagnostics and pharmaceutical research is accelerating the development of more precise and efficient analytical methods. In May 2022, a recent study published in the PLOS ONE Journal highlighted the use of gel electrophoresis to identify key proteins associated with tumor progression and molecular specificity in lung cancer subtypes. This technique allowed researchers to distinguish proteins from tumor cells, which can aid in accurate diagnosis and potentially contribute to the development of targeted therapies for specific lung cancer segments.

Technological advancements in electrophoresis kits and reagents have been transformative, enhancing the efficiency, accuracy, and versatility of electrophoretic techniques across various scientific and clinical applications. One key development lies in the formulation of novel gel matrices for gel electrophoresis, which offer improved resolution and faster separation of biomolecules such as DNA, RNA, and proteins. For instance, in September 2022, miniPCR bio, a leading provider of scientific equipment for researchers, introduced the BanditTM STEM Electrophoresis Kit, an innovative educational tool that enables students to construct and operate a fully functional gel electrophoresis device at an affordable price. This kit is designed to promote hands-on learning in the field of STEM education.

The market is further characterized by the integration of automated systems and robotics in electrophoresis platforms which has streamlined laboratory workflows. Automated electrophoresis instruments leverage microfluidic chip-based technology to seamlessly incorporate fluorescence detection, electrophoretic separation, and data analysis of biomolecules like proteins and nucleic acids into a single platform. For instance, the Experion analysis chip employs LabChip technology developed by Caliper Life Sciences, Inc. This microfluidic chip serves as a powerful, miniaturized laboratory, encapsulating the capabilities of multiple larger benchtop analytical instruments. Each chip features a network of microchannels that link the sample wells to a separation channel and buffer wells.

Furthermore, automated gel loading, sample handling, and data analysis processes minimize human error and improve reproducibility, making electrophoresis more accessible and reliable for researchers and clinicians. In addition, advancements in single-cell proteomics and plasma biomarker discovery are also boosting the need for electrophoresis technologies with higher throughput and reproducibility. Automation and miniaturization of electrophoresis workflows are key focus areas to meet these evolving research requirements.

Governments’ initiatives, increasing funding, and substantial investments in genomics and proteomics are also driving the market growth. Major initiatives like the Yale Center for Genomics and Proteomics and the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium are providing significant funding to advance genomics and proteomics research. This is driving demand for high-performance electrophoresis reagents and systems to support these efforts. Furthermore, in October 2023, the Government of Canada announced an investment of USD 15 million over 5 years to create the Pan-Canadian Genome Library, the country's first national, centralized genomic data management system. The Library will allow for more personalized treatment of diseases, especially rare diseases. Such initiatives aimed at research building capabilities are poised to drive demand for electrophoresis systems and reagents.

Product Insights

The electrophoresis reagents accounted for the largest revenue share of 41.6% in 2023. Reagents, including gels, buffers, dyes, and markers, are essential components that enable and enhance the separation and analysis of molecules. The market is experiencing growth due to several factors related to these reagents. Firstly, ongoing advancements in reagent formulations are improving separation resolution, sensitivity, and specificity, allowing for more accurate and detailed analyses. Recently, in July 2022 National Clinical Trial Registry reported various clinical trials conducted aimed at evaluating the serum inflammation profiles of patients hospitalized with SARS-CoV-2 infections using protein electrophoresis. Thus, such growing research and development activity in developing effective treatments is expected to drive demand for electrophoresis reagents, highlighting the importance of these tools in advancing medical innovation.

The electrophoresis reagents segment is anticipated to grow at the fastest rate of 6.1% CAGR over the forecast period. The development of specialized reagents for specific applications, such as fluorescent dyes for real-time DNA analysis or high-sensitivity protein stains, is further expanding the utility of electrophoresis across various research and diagnostic areas. Additionally, the increasing demand for ready-to-use, standardized reagent kits is making electrophoresis more accessible to a broader range of users, including smaller laboratories and educational institutions.

Application Insights

The research applications segment dominated the market and accounted for the largest share of 52.2% in 2023. Electrophoresis technique is used in various research applications, playing a crucial role in the separation, identification, and analysis of macromolecules such as DNA, RNA, and proteins. In genomics and proteomics research, electrophoresis is used to analyze genetic material and protein expression patterns, aiding in the understanding of gene function and protein interactions. It is also instrumental in molecular cloning, where it helps verify the insertion of genes into plasmids. In biochemistry, electrophoresis facilitates the study of enzyme activities and the purity of synthesized compounds.

The research applications segment is anticipated to grow at the fastest rate of 6.2% Furthermore, its application in forensic science for DNA fingerprinting and paternity testing underscores its versatility. The technique’s precision and reliability make it a cornerstone in laboratories, driving advancements in biotechnology, medical research, and drug development.

End Use Insights

The academic and research institutes segment dominated the end use segments with the largest market share of 34.3% in 2023. These institutions are at the forefront of developing new electrophoresis techniques, applications, and methodologies, often through collaborative projects with industry partners. Their fundamental research in areas such as genomics, proteomics, and molecular biology continuously expands the potential applications of electrophoresis. Universities and research centers are major consumers of electrophoresis equipment and reagents, driving demand through their diverse range of projects and studies. They also serve as training grounds for future scientists and technicians, fostering widespread adoption of electrophoresis techniques. Many breakthrough discoveries and improvements in electrophoresis technology originate from academic research, later translating into commercial products.

The pharmaceutical and biotechnology companies segment is anticipated to grow at the fastest rate of 6.1% CAGR over the forecast period. The rise in personalized medicine and biopharmaceuticals has increased the demand for advanced electrophoresis systems to analyze complex biological molecules with high precision. Additionally, the growing focus on protein-based drugs and genetic therapies necessitates robust electrophoresis methodologies for protein characterization and nucleic acid analysis. Strategic partnerships, mergers, and acquisitions within the industry further stimulate market growth by fostering innovation and expanding the application scope of electrophoresis technologies. As these companies continue to seek more efficient and accurate diagnostic tools, their influence significantly propels the advancement and adoption of electrophoresis techniques worldwide.

Regional Insights

North America electrophoresis market dominated the market and accounted for a 35.4% share in 2023. This high share is attributable to the increasing prevalence of chronic diseases in the region, coupled with high demand for advanced diagnostic tools and personalized medicine further accelerates market growth. According to a report published by the Public Health Agency of Canada in October 2021, approximately 2 in 5 Canadians can expect to receive a cancer diagnosis at some point in their lifetime. In 2021, an estimated 21,000 Canadians died with lung cancer, while the breast, colorectal, and prostate cancers being the most prevalent, accounting for nearly half of all cancer diagnoses that year. In addition, technological advancements and widespread adoption across various scientific and clinical disciplines. This region's market is driven by a strong presence of key players in the biotechnology and pharmaceutical industries in the countries like U.S., alongside substantial investments in research and development.

U.S. Electrophoresis Market Trends

The electrophoresis market in the U.S. is expected to grow substantially over the forecast period. Owing to the rising incidence of cancer and cardiovascular diseases in the country, along with advancements in molecular diagnostics and personalized medicine, is expected to significantly contribute to the market growth. Further, the increasing adoption of NGS technologies is driving the demand for high-performance electrophoresis instruments and reagents in the country.

The U.S. electrophoresis market is expected to expand substantially, offering promising opportunities for innovation and development in molecular biology, clinical diagnostics, and biopharmaceutical research. Further advent of demand for electrophoresis techniques, such as gel electrophoresis and capillary electrophoresis, play crucial roles in analyzing biomolecules like DNA, RNA, and proteins, which are essential for understanding genetic variations and disease mechanisms. This demand is further fueled by advancements in genetic research and the need for accurate disease diagnosis and treatment planning.

Europe Electrophoresis Market Trends

Europe electrophoresis market was identified as a lucrative region in this industry. Driven by the increasing demand for advanced life science research and diagnostics. The region's strong presence of pharmaceutical and biotechnology companies, research institutions, and government funding for life science research have contributed to the electrophoresis market growth. The prevalence of chronic diseases is rising in European countries such as the UK and Germany. For instance, the British Heart Foundation's July 2022 report highlighted that 7.6 million people in the UK lived with heart and circulatory diseases in 2021, of which 4 million were men and 3.6 million were women. Therefore, the high prevalence of heart disease is likely to boost the need for early diagnosis, accompanied by the use of electrophoresis reagents and systems.

Asia Pacific Electrophoresis Market Trends

Asia Pacific electrophoresis market is anticipated to witness the fastest growth of 6.1f% CAGR over the forecast period. This is due to market due to increasing industry academia collaborations in countries like India, China, and Japan. For instance, in February 2023, an institutional collaboration between Kyushu Institute of Technology and Tohoku University in Japan, developed a new type of electrophoresis system that integrates microfluidic and electrochemical sensing technologies. This innovation aims to improve the efficiency and accuracy of biomolecule analysis, such as proteins and DNA fragments. The system utilizes a combination of microfluidic channels and integrated electrodes to achieve rapid separation and detection of biomolecules. Additionally, the expansion of healthcare infrastructure and the implementation of public health initiatives aimed at reducing application abuse during pregnancy are contributing to market growth in this region.

Key Electrophoresis Company Insights

Some of the key players operating in the market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Shimadzu Corporation. and others. The market is highly competitive, with a large number of manufacturers accounting for a majority of the share. New source developments, mergers and acquisitions, and collaborations are some of the major strategies adopted by these players to counter the stiff competition.

Recent Developments

• In January 2024, Agilent Technologies announced a new automated parallel capillary electrophoresis ‘ProteoAnalyzer’ system designed to enhance proteomics research and analysis capabilities. The system integrated advanced liquid chromatography with mass spectrometry (LC-MS) technologies, offering improved sensitivity and throughput for protein characterization and identification. This innovation aimed to address the growing demand for high-resolution proteomics solutions in pharmaceutical research, biomarker discovery, and clinical diagnostics.

• In September 2022, Amerigo Scientific, a leading distributor of products and services to the biomedical and life science industries, launched its new CALX8 Reagent, designed to meet the needs of life science laboratory researchers. The CALX8 Reagent is a versatile tool used in various molecular biology applications, including cell lysis, protein purification, electrophoresis, and immunoassays.

• In June 202, Advanced Electrophoresis Solution Ltd. secured a pre-A investment from GCI Capital and Celtic House Asia Partners, both based in Toronto. This funding will support the company's expansion of its electrophoresis product pipeline and other strategic initiatives.

Electrophoresis Market Report Scope

Global Electrophoresis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global electrophoresis market report based on product, application, end use, and region:

• Electrophoresis Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Electrophoresis Reagents

    • Protein Electrophoresis Reagents

    • Nucleic Acid Electrophoresis Reagents

  • Electrophoresis Systems

    • Gel Electrophoresis Systems

    • Capillary Electrophoresis Systems

  • Gel Documentation Systems

  • Software

• Electrophoresis Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Research Applications

  • Diagnostics Applications

  • Quality Control and Process Validation

• Electrophoresis End use Outlook (Revenue, USD Million, 2018 - 2030)

  • Academic and Research Institutes

  • Pharmaceutical & Biotechnology Companies

  • Hospital & Diagnostic Centers

  • Other End use

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE

    • Kuwait